Abstract
The microbial metabolism of primaquine, a 6-methoxy-8-aminoquinoline antimalarial agent, was investigated. The yeast Candida tropicalis was found to convert primaquine to the previously reported N-acetylated derivative. On continued incubation of C. tropicalis in the presence of the N-acetylated derivative, a minor dimeric metabolite was formed. The proposed structure of the metabolite was based primarily on the analysis of its spectroscopic properties (1H and 13C nuclear magnetic resonance spectra and field-desorption mass spectrum). The structure of the metabolite was proven by direct comparison with an authentic sample of the minor dimeric metabolite prepared by treatment of the N-acetylated derivative with formaldehyde in the presence of formic acid in methanol.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baker J. K., McChesney J. D., Hufford C. D., Clark A. M. High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. J Chromatogr. 1982 Jun 11;230(1):69–77. doi: 10.1016/s0378-4347(00)81431-0. [DOI] [PubMed] [Google Scholar]
- Clark A. M., Huford C. D., McChesney J. D. Primaquine: metabolism by microorganisms and 13C nuclear magnetic resonance assignments. Antimicrob Agents Chemother. 1981 Feb;19(2):337–341. doi: 10.1128/aac.19.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmidt L. H. Chemotherapy of the drug-resistant malarias. Annu Rev Microbiol. 1969;23:427–454. doi: 10.1146/annurev.mi.23.100169.002235. [DOI] [PubMed] [Google Scholar]